This medication is better known as Rimonabant. It is an anti-obesity drug that was originally approved in Europe in June of 2006. Unfortunately, it has not yet been approved for use in the United States. Whenever Zimulti, as it will be called, is approved, it will be the first in a new class of therapeutic agents that are known as Cannabinoid-1 Receptor Blocker (CB1). This class of medication is meant to treat obesity and its related conditions
How This Medication Works
Acomplia is used in addition to a proper diet and exercise program. Therein it is able to treat obesity in patients who suffer from Type 2 diabetes as well as also suffering from abnormal levels of fat in the blood. Sometimes this medication can also help to prevent the risk of cardiovascular disease.
How This Medication Should Be Taken
Most commonly, doctors prescribe one 20mg tablet that is to be taken once each day. This should be done in the morning, after breakfast, and the tablet should be swallowed without crushing.